Video

Q&A with David Milan from Massachusetts General Hospital: Research Helps Raise Awareness for Fibromusclar Dysplasia

Author(s):

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

David J. Milan, MD, from Massachusetts General Hospital discussed research that is being done for the condition during the American Heart Association's annual meeting in Orlando.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.